2023: Πρόγραμμα Μεταπτυχιακών Σπουδών: «Νεοπλασματική Νόσος στον Άνθρωπο: Έρευνα και Κλινικοπαθολογοανατομική Προσέγγιση στα Πλαίσια της Εξατομικευμένης Ιατρικής (Διάγνωση και Στοχευμένη Θεραπεία)»
2025: Is it time to revisit the significance of PD-L1 expression in assisting our treatment decisions?
2025: Acute phantosmia as the first manifestation of brain metastases in a patient with breast cancer. Case report.
2024: Non-Alcoholic Wernicke Encephalopathy in a Young Patient with Adenocarcinoma of the Colon: A Case Report and Review of the Literature
2024: Combining Immunotherapy with PARP inhibitors. Is it possible to find the way through?
2024: Διερεύνηση του ρόλου της μεθυλίωσης των υποκινητών του DNA ως βιοδείκτη στον καρκίνο του πνεύμονα
2023: PARP Inhibitors in Colorectal Malignancies: A 2023 update
2023: Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations
2023: Is The Patient Actually Failing On Enzalutamide? A Case Report And Issues To Consider In Enzalutamide-Resistant Oligo Progressive Metastatic Castrate-Resistant Prostate Cancer
2023: Immune checkpoint inhibitors and combinations with other agents in cholangiocarcinoma
2021: Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer
2021: Perforated appendicitis induced by pembrolizumab: a case report and review of the literature
2018: Myeloablative chemotherapy and autologous stem cell transplantation can lead to successful postengraftment mobilization of hematopoietic progenitors to support planned subsequent cycle(s) of high-dose chemotherapy and autografting in a patient with relapsed germ-cell tumor
